Proteolysis and sterol regulation

Annual Review of Cell and Developmental Biology

Volumn 18, Issue , 2002, Pages 345-378

  Hampton, Randolph Y ^a  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

ER; HMG CoA reductase; HRD pathway; SREBP; Sterols; Ubiquitin

Indexed keywords

HELIX LOOP HELIX PROTEIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE; LOW DENSITY LIPOPROTEIN RECEPTOR; MEMBRANE PROTEIN; STEROL; STEROL REGULATORY ELEMENT BINDING PROTEIN; ZARAGOZIC ACID A; CCAAT ENHANCER BINDING PROTEIN; DNA BINDING PROTEIN; PEPTIDE HYDROLASE; SREBF1 PROTEIN, HUMAN; STEROL REGULATORY ELEMENT BINDING PROTEIN 1; TRANSCRIPTION FACTOR; UBIQUITIN;

AMINO ACID SEQUENCE; BINDING KINETICS; BINDING SITE; CALCIUM SIGNALING; CHROMOSOME TRANSLOCATION; CYTOLOGY; ENDOPLASMIC RETICULUM; ENZYME ACTIVITY; ENZYME DEGRADATION; GENETIC ANALYSIS; GENETIC TRANSCRIPTION; MEMBRANE BINDING; MOLECULAR DYNAMICS; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; QUALITY CONTROL; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; ANIMAL; EUKARYOTIC CELL; HUMAN; METABOLISM; PHYSIOLOGY; REGULATOR GENE;

MAMMALIA; VERTEBRATA;

ANIMALS; CCAAT-ENHANCER-BINDING PROTEINS; DNA-BINDING PROTEINS; EUKARYOTIC CELLS; GENES, REGULATOR; HUMANS; HYDROXYMETHYLGLUTARYL COA REDUCTASES; PEPTIDE HYDROLASES; STEROL REGULATORY ELEMENT BINDING PROTEIN 1; STEROLS; TRANSCRIPTION FACTORS; UBIQUITIN;

EID: 0036437316     PISSN: 10810706     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.cellbio.18.032002.131219     Document Type: Review

References (212)

1. Basson ME, Thorsness M, Finer MJ, Stroud RM, Rine J. 1988. Structural and functional conservation between yeast and human 3-hydroxy-3-methylglutaryl coenzyme A reductases, the rate-limiting enzymes of sterol biosynthesis. Mol. Cell. Biol. 8:3797-808
2. Basson ME, Thorsness M, Rine J. 1986. Saccharomyces cerevisiae contains two functional genes encoding 3-hydroxy-3-methyl-glutaryl-coenzyme A reductase. Proc. Natl. Acad. Sci. USA 83:5563-67
3. Bays NW, Gardner RG, Seelig LP, Joazeiro CA, Hampton RY. 2001a. Hrd1p/Der3p is a membrane-anchored ubiquitin ligase required for ER-associated degradation. Nat. Cell Biol. 3:24-29
4. Bays NW, Hampton RY. 2002. Cdc48p/Np14p/ Ufd1p: Stuck in the middle with Ub. Curr. Biol. 12:R366-71
5. Bays NW, Wilhovsky SK, Goradia A, Hodgkiss-Harlow K, Hampton RY. 2001b. HRD4/NPL4 is required for the proteasomal processing of ubiquitinated ER proteins. Mol. Biol. Cell 12:4114-28
6. Beersma MF, Bijlmakers MJ, Ploegh HL. 1993. Human cytomegalovirus down-regulates HLA class I expression by reducing the stability of class I H chains. J. Immunol. 151:4455-64
7. Bell JJ, Sargeant TE, Watson JA. 1976. Inhibition of 3-hydroxy-3-methylglutaryl coenzyme A reductase activity in hepatoma tissue culture cells by pure cholesterol and several cholesterol derivatives. Evidence supporting two distinct mechanisms. J. Biol. Chem. 251:1745-58
8. Biunno I, Bernard L, Dear P, Cattaneo M, Volorio S, et al. 2000. SEL1L, the human homolog of C. elegans sel-l: Refined physical mapping, gene structure and identification of polymorphic markers. Hum. Genet. 106:227-35
9. Bochtler M, Ditzel L, Groll M, Hartmann C, Huber R. 1999. The proteasome. Annu. Rev. Biophys. Biomol. Struct. 28:295-317
10. Bonfanti L, Mironov AA Jr, Martinez-Menarguez JA, Martella O, Fusella A, et al. 1998. Procollagen traverses the Golgi stack without leaving the lumen of cisternae: Evidence for cisternal maturation. Cell 95:993-1003
11. Bonifacino JS, Lippincott SJ. 1991. Degradation of proteins within the endoplasmic reticulum. Curr. Opin. Cell Biol. 3:592-600
12. Bonifacino JS, Weissman AM. 1998. Ubiquitin and the control of protein fate in the secretory and endocytic pathways. Annu. Rev. Cell Dev. Biol. 14:19-57
13. Bordallo J, Plemper RK, Finger A, Wolf DH. 1998. Der3p/Hrd1p is required for endoplasmic reticulum-associated degradation of misfolded lumenal and integral membrane proteins. Mol. Biol. Cell 9:209-22
14. Bordallo J, Wolf DH. 1999. A RING-H2 finger motif is essential for the function of Der3/Hrd1 in endoplasmic reticulum associated protein degradation in the yeast Saccharomyces cerevisiae. FEBS Lett. 448:244-48
15. Boucher Y, Huber H, L'Haridon S, Stetter KO, Doolittle WF. 2001. Bacterial origin for the isoprenoid biosynthesis enzyme HMG-CoA reductase of the archaeal orders Thermoplasmatales and Archaeoglobales. Mol. Biol. Evol. 18:1378-88
16. Braun S, Matuschewski K, Rape M, Thoms S, Jentsch S. 2002. Role of the ubiquitin-selective CDC48(UFD1/NPL4) chaperone (segregase) in ERAD of OLE1 and other substrates. EMBO J. 21:615-21
17. Brodsky JL, McCracken AA. 1999. ER protein quality control and proteasome-mediated protein degradation. Semin. Cell Dev. Biol. 10:507-13
18. Brown CR, Hong-Brown LQ, Biwersi J, Verkman AS, Welch WJ. 1996. Chemical chaperones correct the mutant phenotype of the delta F508 cystic fibrosis transmembrane conductance regulator protein. Cell Stress Chaperones 1:117-25
19. Brown MS, Dana SE, Goldstein JL. 1973. Regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase activity in human fibroblasts by lipoproteins. Proc. Natl. Acad. Sci. USA 70:2162-66
20. Brown MS, Goldstein JL. 1996. Michael S. Brown, MD and Joseph L. Goldstein, MD. 1985 Nobel laureates in medicine. J. Invest. Med. 44:14-23
21. Brown MS, Goldstein JL. 1997. The SREBP pathway: Regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor. Cell 89:331-40
22. Brown MS, Ye J, Rawson RB, Goldstein JL. 2000. Regulated intramembrane proteolysis: A control mechanism conserved from bacteria to humans. Cell 100:391-98
23. Buhman KK, Chen HC, Farese RV Jr. 2001. The enzymes of neutral lipid synthesis. J. Biol. Chem. 276:40369-72
24. Burke R, Nellen D, Bellotto M, Hafen E, Senti KA, et al. 1999. Dispatched, a novel sterolsensing domain protein dedicated to the release of cholesterol-modified hedgehog from signaling cells. Cell 99:803-15
25. Carstea ED, Morris JA, Coleman KG, Loftus SK, Zhang D, et al. 1997. Niemann-Pick C1 disease gene: Homology to mediators of cholesterol homeostasis. Science 277:228-31
26. Chang TY, Limanek JS. 1980. Regulation of cytosolic acetoacetyl coenzyme A thiolase, 3-hydroxy-3-methylglutaryl coenzyme A synthase, 3-hydroxy-3-methylglutaryl coenzyme A reductase, and mevalonate kinase by low density lipoprotein and by 25-hy-droxycholesterol in Chinese hamster ovary cells. J. Biol. Chem. 255:7787-95
27. Chen ZJ, Parent L, Maniatis T. 1996. Sitespecific phosphorylation of IkappaBalpha by a novel ubiquitination-dependent protein kinase activity. Cell 84:853-62
28. Cheng D, Espenshade PJ, Slaughter CA, Jaen JC, Brown MS, Goldstein JL. 1999a. Secreted site-1 protease cleaves peptides corresponding to luminal loop of sterol regulatory element-binding proteins. J. Biol. Chem. 274:22805-12
29. Cheng HH, Xu L, Kumagai H, Simoni RD. 1999b. Oligomerization state influences the degradation rate of 3-hydroxy-3-methyl-glutaryl-CoA reductase. J. Biol. Chem. 274:17171-78
30. Chin DJ, Gil G, Faust JR, Goldstein JL, Brown MS, Luskey KL. 1985. Sterols accelerate degradation of hamster 3-hydroxy-3-methylglutaryl coenzyme A reductase encoded by a constitutively expressed cDNA. Mol. Cell. Biol. 5:634-41
31. Chin DJ, Luskey KL, Faust JR, MacDonald RJ, Brown MS, Goldstein JL. 1982. Molecular cloning of 3-hydroxy-3-methylglutaryl coenzyme a reductase and evidence for regulation of its mRNA. Proc. Natl. Acad. Sci. USA 79:7704-8
32. Chu PM, Vu JH, Proske RJ, Slaughter CA, DeMartino GN. 1994. Identification, purification, and characterization of a high molecular weight, ATP-dependent activator (PA700) of the 20 S proteasome. J. Biol. Chem. 269:3539-47
33. Chun KT, Bar NS, Simoni RD. 1990. The regulated degradation of 3-hydroxy-3-methylglutaryl-CoA reductase requires a short-lived protein and occurs in the endoplasmic reficulum. J. Biol. Chem. 265:22004-10
34. Chun KT, Simoni RD. 1992. The role of the membrane domain in the regulated degradation of 3-hydroxy-3-methylglutaryl coenzyme A reductase. J. Biol. Chem. 267:4236-46
35. Ciechanover A, Schwartz AL. 2002. Ubiquitin-mediated degradation of cellular proteins in health and disease. Hepatology 35:3-6
36. Cohen J, Gaw A, Barnes RI, Landschulz KT, Hobbs HH. 1996. Genetic factors that contribute to interindividual variations in plasma low density lipoprotein-cholesterol levels. Ciba Found. Syrup. 197:194-206, 10
37. Correll CC, Ng L, Edwards PA. 1994. Identification of famesol as the non-sterol derivative of mevalonic acid required for the accelerated degradation of 3-hydroxy-3-methylglutaryl-coenzyme A reductase. J. Biol. Chem. 269; 17390-93
38. Creagh EM, Martin SJ. 2001. Caspases: Cellular demolition experts. Biochem. Soc. Trans. 29:696-702
39. Cronin S, Hampton RY. 1999. Measuring protein degradation with GFP. Meth. Enzymol. 302:58-73
40. Cronin S, Rao R, Hampton RY. 2002. Cod1p/ Spf1 is an ER P-type ATPase required for ER function and calcium homeostasis. J. Cell Biol. 157:In press
41. Cronin SR, Khoury A, Ferry DK, Hampton RY. 2000. Regulation of HMG-CoA reductase degradation requires the P-type ATPase Cod1p/Spf1p. J. Cell Biol. 148:915-24
42. Dai RM, Li CC. 2001. Valosin-containing protein is a multi-ubiquitin chain-targeting factor required in ubiquitin-proteasome degradation. Nat. Cell Biol. 3:740-44
43. Dawson PA, Metherall JE, Ridgway ND, Brown MS, Goldstein JL. 1991. Genetic distinction between sterol-mediated transcriptional nd posttranscriptional control of 3-hydroxy-3-methylglutaryl-coenzyme A reductase. J. Biol. Chem. 266:9128-34
44. DeBose-Boyd RA, Brown MS, Li WP, Nohturfft A, Goldstein JL, Espenshade PJ. 1999. Transport-dependent proteolysis of SREBP: Relocation of site-1 protease from Golgi to ER obviates the need for SREBP transport to Golgi. Cell 99:703-12
45. DeMartino GN, Moomaw CR, Zagnitko OP, Proske RJ, Chu PM, et al. 1994. PA700, an ATP-dependent activator of the 20 S proteasome, is an ATPase containing multiple members of a nucleotide-binding protein family. J. Biol. Chem. 269:20878-84
46. DeMartino GN, Slaughter CA. 1999. The proteasome, a novel protease regulated by multiple mechanisms. J. Biol. Chem. 274:22123-26
47. Deshaies RJ. 1999. SCF and cullin/RING H2-based ubiquitin ligases. Annu. Rev. Cell Dev. Biol. 15:435-67
48. Dobrosotskaya IY, Seegmiller AC, Brown MS, Goldstein JL, Rawson RB. 2002. Regulation of SREBP processing and membrane lipid production by phospholipids in Drosophila. Science 296:879-83
49. Dodson G, Wlodawer A. 1998. Catalytic triads and their relatives. Trends Biochem. Sci. 23:347-52
50. Dominguez DI, De Strooper B, Annaert W. 2001. Secretases as therapeutic targets for the treatment of Alzheimer's disease. Amyloid 8:124-42
51. Donald KA, Hampton RY, Fritz IB. 1997. Effects of overproduction of the catalytic domain of 3-hyctroxy-3-methylglutaryl coenzyme A reductase on squalene synthesis in Saccharomyces cerevisiae. Appl. Environ. Microbiol. 63:3341-44
52. Donoviel DB, Donoviel MS, Fan E, Hadjantonakis A, Bernstein A. 1998. Cloning and characterization of Sel-11, a murine homolog of the C. elegans sel-1 gene. Mech. Dev. 78:203-7
53. Duncan EA, Brown MS, Goldstein JL, Sakai J. 1997. Cleavage site for sterol-regulated protease localized to a leu-Ser bond in the lumenal loop of sterol regulatory element-binding protein-2. J. Biol. Chem. 272:12778-85
54. Duncan EA, Dave UP, Sakai J, Goldstein JL, Brown MS. 1998. Second-site cleavage in sterol regulatory element-binding protein occurs at transmembrane junction as determined by cysteine panning. J. Biol. Chem. 273:17801-9
55. Edwards PA, Kast HR, Anisfeld AM. 2002. BAREing it all. The adoption of lxr and fxr and their roles in lipid homeostasis. J. Lipid. Res. 43:2-12
56. Edwards PA, Lan SF, Fogelman AM. 1983a. Alterations in the rates of synthesis and degradation of rat liver 3-hydroxy-3-methyl-glutaryl coenzyme A reductase produced by cholestyramine and mevinolin. J. Biol. Chem. 258:10219-22
57. Edwards PA, Lan SF, Tanaka RD, Fogelman AM. 1983b. Mevalonolactone inhibits the rate of synthesis and enhances the rate of degradation of 3-hydroxy-3-methylglutaryl coenzyme A reductase in rat hepatocytes. J. Biol. Chem. 258:7272-75
58. Espenshade PJ, Cheng D, Goldstein JL, Brown MS. 1999. Autocatalytic processing of site-1 protease removes propeptide and permits cleavage of sterol regulatory element-binding proteins. J. Biol. Chem. 274:22795-804
59. Fang S, Ferrone M, Yang C, Jensen JP, Tiwari S, Weissman AM. 2001. The tumor autocrine motility factor receptor, gp78, is a ubiquitin protein ligase implicated in degradation from the endoplasmic reticulum. Proc. Natl. Acad. Sci. USA 98:14422-27
60. Fang S, Jensen JP, Ludwig RL, Vousden KH, Weissman AM. 2000. Mdm2 is a RING fnger-dependent ubiquitin protein ligase for itself and p53. J. Biol. Chem. 275:8945-51
61. Faust JR, Luskey KL, Chin DJ, Goldstein JL, Brown MS. 1982. Regulation of synthesis and degradation of 3-hydroxy-3-methylglutaryl-coenzyme A reductase by low density lipoprotein and 25-hydroxycholesterol in UT-1 cells. Proc. Natl. Acad. Sci. USA 79:5205-9
62. Field RB, Holmlund CE. 1977. Isolation of 2,3;22,23-dioxidosqualene and 24,25-oxidolanosterol from yeast. Arch. Biochem. Biophys. 180:465-71
63. Finley D, Tanaka K, Mann C, Feldmann H, Hochstrasser M, et al. 1998. Unified nomenclature for subunits of the Saccharomyces cerevisiae proteasome regulatory particle. Trends Biochem. Sci. 23:244-45
64. Fisher EA, Zhou M, Mitchell DM, Wu X, Omura S, et al. 1997. The degradation of apolipoprotein B100 is mediated by the ubiquitin-proteasome pathway and involves heat shock protein 70. J. Biol. Chem. 272:20427-34
65. Fitzky BU, Moebius FF, Asaoka H, Waage-Baudet H, Xu L, et al. 2001. 7-Dehydrocholesterol-dependent proteolysis of HMG-CoA reductase suppresses sterol biosynthesis in a mouse model of Smith-Lemli-Opitz/RSH syndrome. J. Clin. Invest. 108:905-15
66. Fitzky BU, Witsch-Baumgartner M, Erdel M, Lee JN, Paik YK, et al. 1998. Mutations in the Delta7-sterol reductase gene in patients with the Smith-Lemli-Opitz syndrome. Proc. Natl. Acad. Sci. USA 95:8181-86
67. Friedlander R, Jarosch E, Urban J, Volkwein C, Sommer T. 2000. A regulatory link between ER-associated protein degradation and the unfolded-protein response. Nat. Cell Biol. 2:379-84
68. Fung B, Holmlund CE. 1976. Effect of triparanol and 3beta-(beta-dimethyl-aminoethoxy)-and rost-5-en-17-one on growth and non-saponifiable lipids of Saccharomyces cerevisiae. Biochem. Pharmacol. 25:1249-54
69. Gardner R, Cronin S, Leader B, Rine J, Hampton R, Leder B. 1998. Sequence determinants for regulated degradation of yeast 3-hydroxy-3-methylglutaryl-CoA reductase, an integral endoplasmic reticulum membrane protein. Mol. Biol. Cell 9:2611-26
70. Gardner RG, Hampton RY. 1999a. A 'distributed degron' allows regulated entry into the ER degradation pathway. EMBO J. 18:5994-6004
71. Gardner RG, Hampton RY. 1999b. A highly conserved signal controls degradation of 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase in eukaryotes. J. Biol. Chem. 274:31671-78
72. Gardner RG, Shan H, Matsuda SP, Hampton RY. 2001a. An oxysterol-derived positive signal for 3-hydroxy-3-methylglutaryl- CoA reductase degradation in yeast. J. Biol. Chem. 276:8681-94
73. Gardner RG, Shearer AG, Hampton RY. 2001b. In vivo action of the hrd ubiquitin ligase complex: Mechanisms of endoplasmic reticulum quality control and sterol regulation. Mol. Cell. Biol. 21:4276-91
74. Gardner RG, Swarbrick GM, Bays NW, Cronin SR, Wilhovsky S, et al. 2000. Endoplasmic reticulum degradation requires lumen to cytosol signaling. Transmembrane control of Hrd1p by Hrd3p. J. Cell Biol. 151:69-82
75. Gieffers C, Dube P, Harris JR, Stark H, Peters JM. 2001. Three-dimensional structure of the anaphase-promoting complex. Mol. Cell 7:907-13
76. Gil G, Faust JR, Chin DJ, Goldstein JL, Brown MS. 1985. Membrane-bound domain of HMG CoA reductase is required for sterol-enhanced degradation of the enzyme. Cell 41:249-58
77. Ginsberg HN. 1997. Role of lipid synthesis, chaperone proteins and proteasomes in the assembly and secretion of apoprotein B-containing lipoproteins from cultured liver cells. Clin. Exp. Pharmacol. Physiol. 24:A29-32
78. Glick BS, Elston T, Oster G. 1997. A cisternal maturation mechanism can explain the asymmetry of the Golgi stack. FEBS Lett. 414:177-81
79. Goldsack NR, Chambers RC, Dabbagh K, Laurent GJ. 1998. Thrombin. Int. J. Biochem. Cell. Biol. 30:641-46
80. Goldstein JL, Brown MS. 1974. Binding and degradation of low density lipoproteins by cultured human fibroblasts. Comparison of cells from a normal subject and from a patient with homozygous familial hypercholes-terolemia. J. Biol. Chem. 249:5153-62
81. Goldstein JL, Brown MS. 1985. The LDL receptor and the regulation of cellular cholesterol metabolism. J. Cell Sci. Suppl. 3:131-37
82. Goldstein JL, Brown MS. 1990. Regulation of the mevalonate pathway. Nature 343:425-30
83. Goldstein JL, Rawson RB, Brown MS. 2002. Mutant mammalian cells as tools to delineate the sterol regulatory element-binding protein pathway for feedback regulation of lipid synthesis. Arch. Biochem. Biophys. 397:139-48
84. Grand-Perret T, Bouillot A, Perrot A, Commans S, Walker M, Issandou M. 2001. SCAP ligands are potent new lipid-lowering drugs. Nat. Med. 7:1332-38
85. Haas D, Kelley RI, Hoffmann GF. 2001. Inherited disorders of cholesterol biosynthesis. Neuropediatrics 32:113-22
86. Halaban R, Svedine S, Cheng E, Smicun Y, Aron R, Hebert DN. 2000. Endoplasmic reticulum retention is a common defect associated with tyrosinase-negative albinism. Proc. Natl. Acad. Sci. USA 97:5889-94
87. Hampton R, Dimster-Denk D, Rine J. 1996a. The biology of HMG-CoA reductase: The pros of contra-regulation. Trends Biochem. Sci. 21:140-45
88. Hampton RY. 2000a. Cholesterol homeostasis: ESCAPe from the ER. Curr. Biol. 10:R298-301
89. Hampton RY. 2000b. ER stress response: Getting the UPR hand on misfolded proteins. Curr. Biol. 10:R518-21
90. Hampton RY, Bhakta H. 1997. Ubiquitin-mediated regulation of 3-hydroxy-3-methylglutaryl-CoA reductase. Proc. Natl. Acad. Sci. USA 94:12944-48
91. Hampton RY, Gardner RG, Rine J. 1996b. Role of 26S proteasome and HRD genes in the degradation of 3-hydroxy-3-methylglutaryl-CoA reductase, an integral endoplasmic reticulum membrane protein. Mol. Biol. Cell 7:2029-44
92. Hampton RY, Koning A, Wright R, Rine J. 1996c. In vivo examination of membrane protein localization and degradation with green fluorescent protein. Proc. Natl. Acad. Sci. USA 93:828-33
93. Hampton RY, Rine J. 1994. Regulated degradation of HMG-CoA reductase, an integral membrane protein of the endoplasmic reticulum, in yeast. J. Cell Biol. 125:299-312
94. Hartmann D, Tournoy J, Saftig P, Annaert W, De Strooper B. 2001. Implication of APP secretases in notch signaling. J. Mol. Neurosci. 17:171-81
95. Hiller MM, Finger A, Schweiger M, Wolf DH. 1996. ER degradation of a misfolded luminal protein by the cytosolic ubiquitin-proteasome pathway. Science 273:1725-28
96. Hitchcock AL, Krebber H, Frietze S, Lin A, Latterich M, Silver PA. 2001. The conserved np14 protein complex mediates proteasome-dependent membrane-bound transcription factor activation. Mol. Biol. Cell 12:3226-41
97. Hochstrasser M. 1996. Ubiquitin-dependent protein degradation. Annu. Rev. Genet. 30:405-39
98. Hooper JE, Scott MP. 1989. The Drosophila patched gene encodes a putative membrane protein required for segmental patterning. Cell 59:751-65
99. Hooper NM. 1994. Families of zinc metalloproteases. FEBS Lett. 354:1-6
100. Hua X, Nohturfft A, Goldstein JL, Brown MS. 1996. Sterol resistance in CHO cells traced to point mutation in SREBP cleavage-activating protein. Cell 87:415-26
101. Hua X, Wu J, Goldstein JL, Brown MS, Hobbs HH. 1995. Structure of the human gene encoding sterol regulatory element binding protein-1 (SREBF1) and localization of SREBF1 and SREBF2 to chromosomes 17p11.2 and 22q13. Genomics 25:667-73
102. Huibregtse JM, Scheffner M, Beaudenon S, Howley PM. 1995. A family of proteins structurally and functionally related to the E6-AP ubiquitin-protein ligase. Proc. Natl. Acad. Sci. USA 92:2563-67. Erratum. 1995. Proc. Natl. Acad. Sci. USA 92(11):5249
103. Inoue S, Bar NS, Roitelman J, Simoni RD. 1991. Inhibition of degradation of 3-hydroxy-3-methylglutaryl-coenzyme A reductase in vivo by cysteine protease inhibitors. J. Biol. Chem. 266:13311-17
104. Inoue S, Simoni RD. 1992. 3-Hydroxy-3-methylglutaryl-coenzyme A reductase and T cell receptor alpha subunit are differentially degraded in the endoplasmic reticulum. J. Biol. Chem. 267:9080-86
105. Janowski BA, Shan B, Russell DW. 2001. The hypocholesterolemic agent LY295427 reverses suppression of sterol regulatory element-binding protein processing mediated by oxysterols. J. Biol. Chem. 276:45408-16
106. Jarosch E, Taxis C, Volkwein C, Bordallo J, Finley D, et al. 2002. Protein dislocation from the ER requires polyubiquitination and the AAA-ATPase Cdc48. Nat. Cell Biol. 4:134-39
107. Joazeiro CA, Weissman AM. 2000. RING finger proteins: Mediators of ubiquitin ligase activity. Cell 102:549-52
108. Keller RK, Zhao Z, Chambers C, Ness GC. 1996. Farnesol is not the nonsterol regulator mediating degradation of HMG-CoA reductase in rat liver. Arch. Biochem. Biophys. 328:324-30
109. Kelley RI, Herman GE. 2001. Inborn errors of sterol biosynthesis. Annu. Rev. Genomics Hum. Genet. 2:299-341
110. Kim JB, Spotts GD, Halvorsen YD, Shih HM, Ellenberger T, et al. 1995. Dual DNA binding specificity of ADD1/SREBP1 controlled by a single amino acid in the basic helixloop-helix domain. Mol. Cell. Biol. 15:2582-88
111. King RW, Deshaies RJ, Peters JM, Kirschner MW. 1996. How proteolysis drives the cell cycle. Science 274:1652-59
112. Klausner RD, Sitia R. 1990. Protein degradation in the endoplasmic reticulum. Cell 62:611-14
113. Kornitzer D, Raboy B, Kulka RG, Fink GR. 1994. Regulated degradation of the transcription factor Gcn4. EMBO J. 13:6021-30
114. Krause G, Hermosilla R, Oksche A, Rutz C, Rosenthal W, Schulein R. 2000. Molecular and conformational features of a transportrelevant domain in the C-terminal tail of the vasopressin V(2) receptor. Mol. Pharmacol. 57:232-42
115. Kumagai H, Chun KT, Simoni RD. 1995. Molecular dissection of the role of the membrane domain in the regulated degradation of 3-hydroxy-3-methylglutaryl coenzyme A reductase. J. Biol. Chem. 270:19107-13
116. Lam WL, Doolittle WF. 1992. Mevinolin-resistant mutations identify a promoter and the gene for a eukaryote-like 3-hydroxy-3-methylglutaryl-coenzyme A reductase in the archaebacterium Haloferax volcanii. J. Biol. Chem. 267:5829-34
117. Laney JD, Hochstrasser M. 1999. Substrate targeting in the ubiquitin system. Cell 97:427-30
118. Lange BM, Rujan T, Martin W, Croteau R. 2000. Isoprenoid biosynthesis: The evolution of two ancient and distinct pathways across genomes. Proc. Natl. Acad. Sci. USA 97:13172-77
119. Le A, Graham KS, Sifers RN. 1990. Intracellular degradation of the transport-impaired human PiZ alpha 1-antitrypsin variant. Biochemical mapping of the degradative event among compartments of the secretory pathway. J. Biol. Chem. 265:14001-7
120. Lecureux LW, Wattenberg BW. 1994. The regulated degradation of a 3-hydroxy-3-methylglutaryl-coenzyme A reductase reporter construct occurs in the endoplasmic reticulum. J. Cell Sci. 107:2635-42
121. Liscum L, Finer-Moore J, Stroud RM, Luskey KL, Brown MS, Goldstein JL. 1985. Domain structure of 3-hydroxy-3-methylglutaryl coenzyme A reductase, a glycoprotein of the endoplasmic reticulum. J. Biol. Chem. 260:522-30
122. Loayza D, Tam A, Schmidt WK, Michaelis S. 1998. Ste6p mutants defective in exit from the endoplasmic reticulum (ER) reveal aspects of an ER quality control pathway in Saccharomyces cerevisiae. Mol. Biol. Cell 9:2767-84
123. Lorick KL, Jensen JP, Fang S, Ong AM, Hatakeyama S, Weissman AM. 1999. RING fingers mediate ubiquitin-conjugating enzyme (E2)-dependent ubiquitination. Proc. Natl. Acad. Sci. USA 96:11364-69
124. Mark M, Muller P, Maier R, Eisele B. 1996. Effects of a novel 2,3-oxidosqualene cyclase inhibitor on the regulation of cholesterol biosynthesis in HepG2 cells. J. Lipid Res. 37:148-58
125. Matsuda M, Korn BS, Hammer RE, Moon YA, Komuro R, et al. 2001. SREBP cleavage-activating protein (SCAP) is required for increased lipid synthesis in liver induced by cholesterol deprivation and insulin elevation. Genes Dev. 15:1206-16
126. McCracken AA, Brodsky JL. 1996. Assembly of ER-associated protein degradation in vitro: Dependence on cytosol, calnexin and ATP. J. Cell Biol. 132:291-98
127. McGee TP, Cheng HH, Kumagai H, Omura S, Simoni RD. 1996. Degradation of 3-hydroxy-3-methylglutaryl-CoA reductase in endoplasmic reticulum membranes is accelerated as a result of increased susceptibility to proteolysis. J. Biol. Chem. 271:25630-38
128. Meigs TE, Roseman DS, Simoni RD. 1996. Regulation of 3-hydroxy-3-methylglutaryl-coenzyme A reductase degradation by the nonsterol mevalonate metabolite farnesol in vivo. J. Biol. Chem. 271:7916-22
129. Meigs TE, Simoni RD. 1992. Regulated degradation of 3-hydroxy-3-methylglutaryl-coenzyme A reductase in permeabilized cells. J. Biol. Chem. 267:13547-52
130. Meigs TE, Simoni RD. 1997. Farnesol as a regulator of HMG-CoA reductase degradation: Characterization and role of famesyl pyrophosphatase. Arch. Biochem. Biophys. 345:1-9
131. Meyer HH, Shorter JG, Seemann J, Pappin D, Warren G. 2000. A complex of mammalian ufd1 and np14 links the AAA-ATPase, p97, to ubiquitin and nuclear transport pathways. EMBO J. 19:2181-92
132. Morand OH, Aebi JD, Dehmlow H, Ji YH, Gains N, et al. 1997. Ro 48-8.071, a new 2,3-oxidosqualene: Lanosterol cyclase inhibitor lowering plasma cholesterol in hamsters, squirrel monkeys, and minipigs: Comparison to simvastatin. J. Lipid. Res. 38:373-90
133. Nakanishi M, Goldstein JL, Brown MS. 1988. Multivalent control of 3-hydroxy-3-methylglutaryl coenzyme A reductase. Mevalonate-derived product inhibits translation of mRNA and accelerates degradation of enzyme. J. Biol. Chem. 263:8929-37
134. Nakano Y, Guerrero I, Hidalgo A, Taylor A, Whittle JR, Ingham PW. 1989. A protein with several possible membrane-spanning domains encoded by the Drosophila segment polarity gene patched. Nature 341:508-13
135. Nauseef WM. 1999. Quality control in the endoplasmic reticulum: Lessons from hereditary myeloperoxidase deficiency. J. Lab. Clin. Med. 134:215-21
136. Nohturfft A, Brown MS, Goldstein JL. 1998a. Sterols regulate processing of carbohydrate chains of wild-type SREBP cleavage-activating protein (SCAP), but not sterol-resistant mutants Y298C or D443N. Proc. Natl. Acad. Sci. USA 95:12848-53
137. Nohturfft A, Brown MS, Goldstein JL. 1998b. Topology of SREBP cleavage-activating protein, a polytopic membrane protein with a sterol-sensing domain. J. Biol. Chem. 273:17243-50
138. Nohturfft A, DeBose-Boyd RA, Scheek S, Goldstein JL, Brown MS. 1999. Sterols regulate cycling of SREBP cleavage-activating protein (SCAP) between endoplasmic reticulum and Golgi. Proc. Natl. Acad. Sci. USA 96:11235-40
139. Nohturfft A, Hua X, Brown MS, Goldstein JL. 1996. Recurrent G-to-A substitution in a single codon of SREBP cleavage-activating protein causes sterol resistance in three mutant Chinese hamster ovary cell lines. Proc. Natl. Acad. Sci. USA 93:13709-14
140. Nohturfft A, Yabe D, Goldstein JL, Brown MS, Espenshade PJ. 2000. Regulated step in cholesterol feedback localized to budding of SCAP from ER membranes. Cell 102:315-23
141. Olender EH, Simon RD. 1992. The intracellular targeting and membrane topology of 3-hydroxy-3-methylglutaryl-CoA reductase. J. Biol. Chem. 267:4223-35
142. Osborne TF. 1991. Single nucleotide resolution of sterol regulatory region in promoter for 3-hydroxy-3-methylglutaryl coenzyme A reductase. J. Biol. Chem. 266:13947-51
143. Osborne TF. 2000. Sterol regulatory element-binding proteins (SREBPs): Key regulators of nutritional homeostasis and insulin action. J. Biol. Chem. 275:32379-82
144. Osborne TF, Rosenfeld JM. 1998. Related membrane domains in proteins of sterol sensing and cell signaling provide a glimpse of treasures still buried within the dynamic realm of intracellular metabolic regulation. Curr. Opin. Lipidol. 9:137-40
145. Page AM, Hieter P. 1999. The anaphase-promoting complex: New subunits and regulators. Annu. Rev. Biochem. 68:583-609
146. Panini SR, Delate TA, Sinensky M. 1992. Post-transcriptional regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase by 24(S),25-oxidolanosterol. J. Biol. Chem. 267:12647-54
147. Panini SR, Schnitzer PR, Spencer TA, Sinensky M. 1989. Sterol-independent regulation of 3-hydroxy-3-methylglutaryl-CoA reductase by mevalonate in Chinese hamster ovary cells. Magnitude and specificity. J. Biol. Chem. 264:11044-52
148. Peffley DM, Gayen AK, Morand OH. 1998. Down-regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase mRNA levels and synthesis in Syrian hamster C100 cells by the oxidosqualene cyclase inhibitor [4′-(6-allyl-ethyl-amino-hexyloxy)-2′-fluorophenyl]-(4- bromophenyl)-methanone (Ro 48-8071): Comparison to simvastatin. Biochem. Pharmacol. 56:439-49
149. Peters JM. 1998. SCF and APC: The Yin and Yang of cell cycle regulated proteolysis. Curt. Opin. Cell Biol. 10:759-68
150. Pilon M, Schekman R, Romisch K. 1997. Sec61p mediates export of a misfolded secretory protein from the endoplasmic reticulum to the cytosol for degradation. EMBO J. 16:4540-48
151. Plemper RK, Bohmler S, Bordallo J, Sommer T, Wolf DH. 1997. Mutant analysis links the translocon and BiP to retrograde protein transport for ER degradation. Nature 388:891-95
152. Plemper RK, Bordallo J, Deak PM, Taxis C, Hitt R, Wolf DH. 1999a. Genetic interactions of Hrd3p and Der3p/Hrd1p with Sec61p suggest a retro-translocation complex mediating protein transport for ER degradation. J. Cell Sci. 112:4123-34
153. Plemper RK, Deak PM, Otto RT, Wolf DH. 1999b. Re-entering the translocon from the lumenal side of the endoplasmic reticulum. Studies on mutated carboxypeptidase yscY species. FEBS Lett. 443:241-45
154. Plemper RK, Egner R, Kuchler K, Wolf DH. 1998. Endoplasmic reticulum degradation of a mutated ATP-binding cassette transporter Pdr5 proceeds in a concerted action of Sec61 and the proteasome. J. Biol. Chem. 273:32848-56
155. Plemper RK, Wolf DH. 1999. Endoplasmic reticulum degradation. Reverse protein transport and its end in the proteasome. Mol. Biol. Rep. 26:125-30
156. Porter JA, Young KE, Beachy PA. 1996. Cholesterol modification of hedgehog signaling proteins in animal development. Science 274:255-59. Erratum. Science 274:1597
157. Rabinovich E, Kerem A, Frohlich KU, Diamant N, Bar-Nun S. 2002. AAA-ATPase p97/Cdc48p, a cytosolic chaperone required for endoplasmic reticulum-associated protein degradation. Mol. Cell. Biol. 22:626-34
158. Rape M, Hoppe T, Gorr I, Kalocay M, Richly H, Jentsch S. 2001. Mobilization of processed, membrane-tethered SPT23 transcription factor by CDC48(UFD1/NPLA), a ubiquitin-selective chaperone. Cell 107:667-77
159. Ravid T, Avner R, Polak-Charcon S, Faust JR, Roitelman J. 1999. Impaired regulation of 3-hydroxy-3-methylglutaryl-coenzyme A reductase degradation in lovastatin-resistant cells. J. Biol. Chem. 274:29341-51
160. Ravid T, Doolman R, Avner R, Harats D, Roitelman J. 2000. The ubiquitin-proteasome pathway mediates the regulated degradation of mammalian 3-hydroxy-3-methylglutaryl-coenzyme A reductase. J. Biol. Chem. 275:35840-47
161. Rawson RB, Cheng D, Brown MS, Goldstein JL. 1998. Isolation of cholesterol-requiring mutant Chinese hamster ovary cells with defects in cleavage of sterol regulatory element-binding proteins at site 1. J. Biol. Chem. 273:28261-69
162. Rawson RB, DeBose-Boyd R, Goldstein JL, Brown MS. 1999. Failure to cleave sterol regulatory element-binding proteins (SREBPs) causes cholesterol auxotrophy in Chinese hamster ovary cells with genetic absence of SREBP cleavage-activating protein. J. Biol. Chem. 274:28549-56
163. Rawson RB, Zelenski NG, Nijhawan D, Ye J, Sakai J, et al. 1997. Complementation cloning of S2P, a gene encoding a putative metalloprotease required for intramembrane cleavage of SREBPs. Mol. Cell 1:47-57
164. Repa JJ, Turley SD, Lobaccaro JA, Medina J, Li L, et al. 2000. Regulation of absorption and ABC1-mediated efflux of cholesterol by RXR heterodimers. Science 289:1524-29
165. Ridgway ND, Lagace TA. 1995. Brefeldin A renders Chinese hamster ovary cells insensitive to transcriptional suppression by 25-hydroxycholesterol. J. Biol. Chem. 270:8023-31
166. Rigotti A, Krieger M. 1999. Getting a handle on "good" cholesterol with the high-density lipoprotein receptor. N. Engl. J. Med. 341:2011-13
167. Roitelman J, Bar-Nun S, Inoue S, Simoni RD. 1991. Involvement of calcium in the mevalonate-accelerated degradation of 3-hydroxy-3-methylglutaryl-CoA reductase. J. Biol. Chem. 266:16085-91
168. Roitelman J, Olender EH, Bar-Nun S, Dunn WA Jr, Simoni RD. 1992. Immunological evidence for eight spans in the membrane domain of 3-hydroxy-3-methylglutaryl coenzyme A reductase: Implications for enzyme degradation in the endoplasmic reticulum. J. Cell Biol. 117:959-73
169. Roitelman J, Simoni RD. 1992. Distinct sterol and nonsterol signals for the regulated degradation of 3-hydroxy-3-methylglutaryl-CoA reductase. J. Biol. Chem. 267:25264-73
170. Rudner DZ, Fawcett P, Losick R. 1999. A family of membrane-embedded metallopro-teases involved in regulated proteolysis of membrane-associated transcription factors. Proc. Natl. Acad. Sci. USA 96:14765-70
171. Russell DW. 2000. Oxysterol biosynthetic enzymes. Biochim. Biophys. Acta 1529:126-35
172. Sakai J, Duncan EA, Rawson RB, Hua X, Brown MS, Goldstein JL. 1996. Sterolregulated release of SREBP-2 from cell membranes requires two sequential cleavages, one within a transmembrane segment. Cell 85:1037-46
173. Sakai J, Nohturfft A, Cheng D, Ho YK, Brown MS, Goldstein JL. 1997. Identification of complexes between the COOH-terminal domains of sterol regulatory element-binding proteins (SREBPs) and SREBP cleavage-activating protein. J. Biol. Chem. 272:20213-21
174. Sakai J, Nohturfft A, Goldstein JL, Brown MS. 1998a. Cleavage of sterol regulatory element-binding proteins (SREBPs) at site-1 requires interaction with SREBP cleavage-activating protein. Evidence from in vivo competition studies. J. Biol. Chem. 273:5785-93
175. Sakai J, Rawson RB, Espenshade PJ, Cheng D, Seegmiller AC, et al. 1998b. Molecular identification of the sterol-regulated luminal protease that cleaves SREBPs and controls lipid composition of animal cells. Mol. Cell 2:505-14
176. Sato R, Yang J, Wang X, Evans MJ, Ho YK, et al. 1994. Assignment of the membrane attachment, DNA binding, and transcriptional activation domains of sterol regulatory element-binding protein-1 (SREBP-1). J. Biol. Chem. 269:17267-73
177. Sato S, Ward CL, Krouse ME, Wine JJ, Kopito RR. 1996, Glycerol reverses the misfolding phenotype of the most common cystic fibrosis mutation. J. Biol. Chem. 271:635-38
178. Seegmiller AC, Dobrosotskaya I, Goldstein JL, Ho YK, Brown MS, Rawson RB. 2002. The SREBP pathway in Drosophila: Regulation by palmitate, not sterols. Dev. Cell 2:229-38
179. Seidah NG, Mowla SJ, Hamelin J, Mamarbachi AM, Benjannet S, et al. 1999. Mammalian subtilisin/kexin isozyme SKI-1: A widely expressed proprotein convertase with a unique cleavage specificity and cellular localization. Proc. Natl. Acad. Sci. USA 96:1321-26
180. Sharkey TD. 1996. Isoprene synthesis by plants and animals. Endeavour 20:74-78
181. Siezen RJ, Leunissen JA. 1997. Subtilases: The superfamily of subtilisin-like serine proteases. Protein Sci. 6:501-23
182. Simons K, Ikonen E. 2000. How cells handle cholesterol. Science 290:1721-26
183. Sinensky M, Torget R, Edwards PA. 1981. Radioimmune precipitation of 3-hydroxy-3-methylglutaryl coenzyme A reductase from Chinese hamster fibroblasts. Effect of 25-hydroxycholesterol. J. Biol. Chem. 256:11774-79
184. Sinensky M, Torget R, Schnitzer-Polokoff R, Edwards PA. 1982. Analysis of regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase in a somatic cell mutant auxotrophic for mevalonate. J. Biol. Chem. 257:7284-86
185. Sommer T, Wolf DH. 1997. Endoplasmic reticulum degradation: Reverse protein flow of no return. FASEB J. 11:1227-33
186. Stafford FJ, Bonifacino JS. 1991. A permeabilized cell system identifies the endoplasmic reticulnm as a site of protein degradation. J. Cell Biol. 115:1225-36
187. Südhof TC, Russell DW, Brown MS, Goldstein JL. 1987. 42 bp element from LDL receptor gene confers end-product repression by sterols when inserted into viral TK promoter. Cell 48:1061-69
188. Suzuki C, Shimma YI, 1999. P-type ATPase spf1 mutants show a novel resistance mechanism for the killer toxin SMKT Mol. Microbiol. 32:813-23
189. Swanson R, Locher M, Hochstrasser M. 2001. A conserved ubiquitin ligase of the nuclear envelope/endoplasmic reticulum that functions in both ER-associated and Matalpha2 repressor degradation. Genes Dev. 15:2660-74
190. Tanaka K, Tsurumi C, 1997, The 26S proteasome: Subunits and functions. Mol. Biol. Rep. 24:3-11
191. Tang Z, Li B, Bharadwaj R, Zhu H, Ozkan E, et al. 2001. APC2 cullin protein and APC11 RING protein comprise the minimal ubiquitin ligase module of the anaphase-promoting complex. Mol. Biol. Cell 12:3839-51
192. Thrower JS, Hoffman L, Rechsteiner M, Pickart CM. 2000. Recognition of the polyubiquitin proteolytic signal. EMBO J. 19:94-102
193. Tontonoz P, Kim JB, Graves RA, Spiegelman BM. 1993. ADD1: A novel helix-loophelix transcription factor associated with adipocyte determination and differentiation. Mol. Cell. Biol. 13:4753-59
194. Travers KJ, Patil CK, Wodicka L, Lockhart DJ, Weissman JS, Walter P. 2000. Functional and genomic analyses reveal an essential coordination between the unfolded protein response and ER-associated degradation. Cell 101:249-58
195. Treier M, Staszewski LM, Bohmann D. 1994. Ubiquitin-dependent c-Jun degradation in vivo is mediated by the delta domain. Cell 78:787-98
196. Vance DE, Van den Bosch H. 2000. Cholesterol in the year 2000. Biochim. Biophys. Acta 1529:1-8
197. Vik A, Rine J. 2001. Upc2p and Ecm22p, dual regulators of sterol biosynthesis in Saccharomyces cerevisiae. Mol. Cell. Biol. 21:6395-405
198. Wang X, Briggs MR, Hua X, Yokoyama C, Goldstein JL, Brown MS. 1993. Nuclear protein that binds sterol regulatory element of low density lipoprotein receptor promoter. II. Purification and characterization. J. Biol. Chem. 268:14497-504
199. Wang X, Sato R, Brown MS, Hua X, Goldstein JL. 1994. SREBP-1, a membrane-bound transcription factor released by sterol-regulated proteolysis. Cell 77:53-62
200. Ward CL, Kopito RR. 1994. Intracellular turnover of cystic fibrosis transmembrane conductance regulator. Inefficient processing and rapid degradation of wild-type and mutant proteins. J. Biol. Chem. 269:25710-18
201. Ward CL, Omura S, Kopito RR. 1995. Degradation of CFTR by the ubiquitin-proteasome pathway. Cell 83:121-27
202. Welch WJ, Brown CR. 1996. Influence of molecular and chemical chaperones on protein folding. Cell Stress Chaperones 1:109-15
203. Werner ED, Brodsky JL, McCracken AA. 1996. Proteasome-dependent endoplasmic reticulum-associated protein degradation: An unconventional route to a familiar fate. Proc. Natl. Acad. Sci. USA 93:13797-801
204. Whyte JR, Munro S. 2001. The Sec34/35 Golgi transport complex is related to the exocyst, defining a family of complexes involved in multiple steps of membrane traffic. Dev. Cell 1:527-37
205. Wiertz EJHJ, Jones TR, Sun L, Bogyo M, Geuze HJ, Ploegh HL. 1996. The human cytomegalovirus US11 gene product dislocates MHC class I heavy chains from the endoplasmic reticulum to the cytosol. Cell 84:769-79
206. Wilhovsky S, Gardner R, Hampton R. 2000. HRD gene dependence of endoplasmic reticulum-associated degradation. Mol. Biol. Cell 11:1697-708
207. Ye J, Rawson RB, Komuro R, Chen X, Dave UP, et al. 2000. ER stress induces cleavage of membrane-bound ATF6 by the same proteases that process SREBPs. Mol. Cell 6:1355-64
208. Ye Y, Meyer HH, Rapoport TA. 2001. The AAA ATPase Cdc48/p97 and its partners transport proteins from the ER into the cytosol. Nature 414:652-56
209. Yokoyama C, Wang X, Briggs MR, Admon A, Wu J, et al. 1993. SREBP-1, a basic-helix-loop-helix-leucine zipper protein that controls transcription of the low density lipoprotein receptor gene. Cell 75:187-97
210. Yu H, Kaung G, Kobayashi S, Kopito RR. 1997. Cytosolic degradation of T-cell receptor alpha chains by the proteasome. J. Biol. Chem. 272:20800-4
211. Zelenski NG, Rawson RB, Brown MS, Goldstein JL. 1999. Membrane topology of S2P, a protein required for intramembranous cleavage of sterol regulatory element-binding proteins. J. Biol. Chem. 274:21973-80
212. Zhou M, Schekman R. 1999. The engagement of Sec61p in the ER dislocation process. Mol. Cell 4:925-34